Dissociation reaction constant k-
Aim: Understand the Law of Mass Action for quantification of drug-receptor interactions. Investigate the role of rate constants and drug concentration in formation of the drug-receptor complexes.
The first step in drug (D) action on specific receptors (R) is the formation of a reversible drug-receptor complex (RD):
$${R + D} {\xrightleftharpoons[k_{-}]{k_{+}}} RD\;\;,\;\; K_{D} = {k_{-} \over k_{+}}$$
The left graph displays the kinetics of the formation of the drug-receptor complexes (RD); the right graph displays the corresponding steady-state levels. Change the drug concentration or the rate constants (\(k_{+}\), \(k_{-}\)) and observe how rapidly binding develops and what fraction of receptors becomes drug-bound. Increasing the drug concentration makes more drug available to interact with the receptor, so binding occurs more rapidly and the equilibrium occupancy increases; a low \(k_{-}\) means the drug remains bound longer, whereas a high \(k_{-}\) produces faster dissociation. Drugs with a lower \(K_D\) reach a given occupancy at lower concentrations.
Choose a parameter set
s-1
Association reaction constant k+
s-1
Drug concentration [D]
µM
Drug–receptor interactions describe the binding of a drug molecule to a specific molecular target, such as a receptor, enzyme, transporter, or ion channel. Binding to the target can alter its function and thereby produce a cellular or physiological response.
In this simulation, the focus is on ion channels as drug targets. Ion channels are membrane proteins that control the movement of ions such as Na+, K+, Ca2+, and Cl− across the cell membrane. Drugs can bind directly to these channels and modify their activity by blocking ion flow, enhancing channel opening, or altering the probability that the channel occupies a particular functional state. The interaction depends on complementary molecular shape, charge, and chemical interactions, so a drug binds more readily to some targets than to others.
An important property of this interaction is binding affinity, which describes how strongly a drug tends to associate with its target. High-affinity drugs can achieve substantial target occupancy at relatively low concentrations, whereas lower-affinity drugs generally require higher concentrations to achieve the same degree of binding.
Affinity alone, however, does not determine the magnitude of a drug’s effect. The physiological response also depends on what happens after binding — for example, whether the drug activates, inhibits, or modifies the function of the ion channel. Understanding these interactions helps explain how drugs selectively alter cellular signalling and electrical activity, and is fundamental to the discovery and development of new medicines.
A dose-response curve is a graph that shows the relationship between the dose of a drug and its physiological response. It is used to understand how the effectiveness of a drug changes as the dose is increased or decreased.
The shape of the curve can vary depending on the drug and the specific response being measured. In general, the curve starts with a flat portion at low doses, where there is little or no response. As the dose increases, the response increases until it reaches a maximum effect. Beyond this point, further increases in the dose do not result in a greater response.
The steepness of the curve can also vary. A steep curve indicates that a small increase in the dose leads to a large increase in the response, while a shallow curve indicates that a larger increase in the dose is needed to produce a similar increase in the response.
The dose-response curve is an important tool for understanding the pharmacological properties of a drug and for determining the optimal dose for a particular response. It is also used to identify the range of doses that produce the desired response without causing harmful side effects.
The dissociation constant \(K_d\) is a quantitative measure of the affinity between a drug and its target. For a simple reversible 1:1 interaction:
$$ D + R \;\rightleftharpoons\; DR \qquad K_d = \frac{[D][R]}{[DR]} = \frac{k_{off}}{k_{on}} $$
where \(D\) is the free drug, \(R\) the unoccupied target, \(DR\) the drug–target complex, and \(k_{on}\) / \(k_{off}\) the association and dissociation rate constants. The value of \(K_d\) indicates the drug concentration required to occupy the target: when the free drug concentration equals \(K_d\), approximately 50% of the available targets are occupied. A low \(K_d\) therefore indicates high affinity — relatively little drug is required to achieve substantial occupancy — whereas a high \(K_d\) indicates lower affinity. For example, a drug with a \(K_d\) of 1 nM occupies about 50% of its targets at a free concentration of 1 nM, assuming simple 1:1 equilibrium binding.
The relationship between drug concentration and fractional target occupancy for simple 1:1 binding is:
$$ \text{Fractional occupancy} = \frac{[D]}{[D] + K_d} $$
So increasing the drug concentration or decreasing \(K_d\) both raise occupancy at a given concentration. Note that \(K_d\) should not be confused with EC50 or IC50, which describe the concentration required to produce a particular functional effect — occupancy and functional response are related but not identical. Experimentally measured \(K_d\) values can also depend on temperature, pH, ionic composition, and the experimental system; for ion channels, affinity may additionally depend on whether the channel is resting, open, or inactivated.